TP53 and cancer: Mutations of the tumor suppressor gene TP53 are detected in ∼50% of all types of human cancers [3], while the functions and stability of the p53 protein are often abrogated via posttranslational mechanisms in the rest of human cancers that contain wild type TP53[4], [5].